Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 967

1.

Additional Ganglion Plexus Ablation During Thoracoscopic Surgical Ablation of Advanced Atrial Fibrillation: Intermediate Follow-Up of the AFACT Study.

Berger WR, Neefs J, van den Berg NWE, Krul SPJ, van Praag EM, Piersma FR, de Jong JSSG, van Boven WP, Driessen AHG, de Groot JR.

JACC Clin Electrophysiol. 2019 Mar;5(3):343-353. doi: 10.1016/j.jacep.2018.10.008. Epub 2018 Nov 28.

PMID:
30898238
2.

Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology.

Prager GW, Unseld M, Waneck F, Mader R, Wrba F, Raderer M, Fuereder T, Staber P, Jäger U, Kieler M, Bianconi D, Hoda MA, Baumann L, Reinthaller A, Berger W, Grimm C, Kölbl H, Sibilia M, Müllauer L, Zielinski C.

Oncotarget. 2019 Jan 29;10(9):942-952. doi: 10.18632/oncotarget.26604. eCollection 2019 Jan 29.

3.

Synthesis, Characterization and in vitro Studies of a Cathepsin B-Cleavable Prodrug of the VEGFR Inhibitor Sunitinib.

Karnthaler-Benbakka C, Koblmüller B, Mathuber M, Holste K, Berger W, Heffeter P, Kowol CR, Keppler BK.

Chem Biodivers. 2019 Jan;16(1):e1800520. doi: 10.1002/cbdv.201800520. Epub 2018 Dec 19.

4.

Persistent atrial fibrillation: A systematic review and meta-analysis of invasive strategies.

Berger WR, Meulendijks ER, Limpens J, van den Berg NWE, Neefs J, Driessen AHG, Krul SPJ, van Boven WJP, de Groot JR.

Int J Cardiol. 2019 Mar 1;278:137-143. doi: 10.1016/j.ijcard.2018.11.127. Epub 2018 Nov 29.

5.

Lysosomal Sequestration Impairs the Activity of the Preclinical FGFR Inhibitor PD173074.

Englinger B, Kallus S, Senkiv J, Laemmerer A, Moser P, Gabler L, Groza D, Kowol CR, Heffeter P, Grusch M, Berger W.

Cells. 2018 Dec 8;7(12). pii: E259. doi: 10.3390/cells7120259.

6.

The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma.

Laszlo V, Valko Z, Ozsvar J, Kovacs I, Garay T, Hoda MA, Klikovits T, Stockhammer P, Aigner C, Gröger M, Klepetko W, Berger W, Grusch M, Tovari J, Waizenegger IC, Dome B, Hegedus B.

J Mol Med (Berl). 2019 Feb;97(2):231-242. doi: 10.1007/s00109-018-1725-7. Epub 2018 Dec 11.

7.

Feasibility of personalized treatment concepts in gastrointestinal malignancies: Sub-group results of prospective clinical phase II trial EXACT.

Unseld M, Mader R, Baumann L, Veraar C, Wrba F, Waneck F, Kieler M, Bianconi D, Berger W, Sibilia M, Müllauer L, Zielinski C, Prager GW.

Chin J Cancer Res. 2018 Oct;30(5):508-515. doi: 10.21147/j.issn.1000-9604.2018.05.04.

8.

Metal Drugs and the Anticancer Immune Response.

Englinger B, Pirker C, Heffeter P, Terenzi A, Kowol CR, Keppler BK, Berger W.

Chem Rev. 2018 Nov 29. doi: 10.1021/acs.chemrev.8b00396. [Epub ahead of print]

PMID:
30489072
9.

Damage to the left internal mammary artery during anterior epicardial access for ventricular tachycardia ablation.

Khan M, Hendriks AA, Yap SC, Berger WR, de Ruiter GS, Szili-Torok T.

HeartRhythm Case Rep. 2018 Aug 14;4(11):534-537. doi: 10.1016/j.hrcr.2018.08.002. eCollection 2018 Nov. No abstract available.

10.

Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature.

Erhart F, Blauensteiner B, Zirkovits G, Printz D, Soukup K, Klingenbrunner S, Fischhuber K, Reitermaier R, Halfmann A, Lötsch D, Spiegl-Kreinecker S, Berger W, Visus C, Dohnal A.

J Cell Mol Med. 2019 Jan;23(1):281-292. doi: 10.1111/jcmm.13927. Epub 2018 Nov 22.

11.

Biological activity of PtIV prodrugs triggered by riboflavin-mediated bioorthogonal photocatalysis.

Alonso-de Castro S, Terenzi A, Hager S, Englinger B, Faraone A, Martínez JC, Galanski M, Keppler BK, Berger W, Salassa L.

Sci Rep. 2018 Nov 21;8(1):17198. doi: 10.1038/s41598-018-35655-2.

12.

Spectroscopy approach to methanol detection in waste fat methyl esters.

Czechlowski M, Marcinkowski D, Golimowska R, Berger WA, Golimowski W.

Spectrochim Acta A Mol Biomol Spectrosc. 2019 Mar 5;210:14-20. doi: 10.1016/j.saa.2018.11.003. Epub 2018 Nov 3.

PMID:
30419453
13.

Logistical and structural challenges are the major obstacles for family medicine physicians' ability to administer adult vaccines.

Equils O, Kellogg C, Baden L, Berger W, Connolly S.

Hum Vaccin Immunother. 2018 Nov 5:1-6. doi: 10.1080/21645515.2018.1543524. [Epub ahead of print]

PMID:
30395771
14.

Synthesis and biological evaluation of biotin-conjugated anticancer thiosemicarbazones and their iron(III) and copper(II) complexes.

Kallus S, Uhlik L, van Schoonhoven S, Pelivan K, Berger W, Enyedy ÉA, Hofmann T, Heffeter P, Kowol CR, Keppler BK.

J Inorg Biochem. 2019 Jan;190:85-97. doi: 10.1016/j.jinorgbio.2018.10.006. Epub 2018 Oct 19.

PMID:
30384010
15.

Neurokinin-3 receptor activation selectively prolongs atrial refractoriness by inhibition of a background K+ channel.

Veldkamp MW, Geuzebroek GSC, Baartscheer A, Verkerk AO, Schumacher CA, Suarez GG, Berger WR, Casini S, van Amersfoorth SCM, Scholman KT, Driessen AHG, Belterman CNW, van Ginneken ACG, de Groot JR, de Bakker JMT, Remme CA, Boukens BJ, Coronel R.

Nat Commun. 2018 Oct 19;9(1):4357. doi: 10.1038/s41467-018-06530-5.

16.

PTSD in mental health outpatient settings: highly prevalent and under-recognized.

da Silva HC, Furtado da Rosa MM, Berger W, Luz MP, Mendlowicz M, Coutinho ESF, Portella CM, Marques PIS, Mograbi DC, Figueira I, Ventura P.

Braz J Psychiatry. 2018 Oct 11. pii: S1516-44462018005007105. doi: 10.1590/1516-4446-2017-0025. [Epub ahead of print]

17.

The thiosemicarbazone Me2NNMe2 induces paraptosis by disrupting the ER thiol redox homeostasis based on protein disulfide isomerase inhibition.

Hager S, Korbula K, Bielec B, Grusch M, Pirker C, Schosserer M, Liendl L, Lang M, Grillari J, Nowikovsky K, Pape VFS, Mohr T, Szakács G, Keppler BK, Berger W, Kowol CR, Heffeter P.

Cell Death Dis. 2018 Oct 15;9(11):1052. doi: 10.1038/s41419-018-1102-z.

18.

FGF8 induces therapy resistance in neoadjuvantly radiated rectal cancer.

Harpain F, Ahmed MA, Hudec X, Timelthaler G, Jomrich G, Müllauer L, Selzer E, Dörr W, Bergmann M, Holzmann K, Grasl-Kraupp B, Grusch M, Berger W, Marian B, Silberhumer GR.

J Cancer Res Clin Oncol. 2019 Jan;145(1):77-86. doi: 10.1007/s00432-018-2757-7. Epub 2018 Oct 1.

19.

Serum-binding properties of isosteric ruthenium and osmium anticancer agents elucidated by SEC-ICP-MS.

Klose MHM, Schöberl A, Heffeter P, Berger W, Hartinger CG, Koellensperger G, Meier-Menches SM, Keppler BK.

Monatsh Chem. 2018;149(10):1719-1726. doi: 10.1007/s00706-018-2280-1. Epub 2018 Aug 25.

20.

Comparison of non-triggered magnetic resonance imaging and echocardiography for the assessment of left atrial volume and morphology.

van den Berg NWE, Chan Pin Yin DRPP, Berger WR, Neefs J, De Bruin-Bon RHACM, Marquering HA, Slaar A, Planken RN, de Groot JR.

Cardiovasc Ultrasound. 2018 Sep 18;16(1):17. doi: 10.1186/s12947-018-0134-y.

21.

Proposal to Reduce Adult Immunization Barriers in California.

Equils O, Kellogg C, Berger W, Hurley-Kim K, Rubinstein E, Kominski G.

Policy Brief UCLA Cent Health Policy Res. 2018 Aug;2018(5):1-6.

PMID:
30199196
22.

Pre-traumatic vs post-traumatic OCD in PTSD patients: Are differences in comorbidity rates and functional health status related to childhood abuse?

Araújo AXG, Fontenelle LF, Berger W, Luz MPD, Pagotto LFADC, Marques-Portella C, Figueira I, Mendlowicz MV.

Compr Psychiatry. 2018 Nov;87:25-31. doi: 10.1016/j.comppsych.2018.08.012. Epub 2018 Aug 25.

PMID:
30195097
23.

Nanoformulations of anticancer FGFR inhibitors with improved therapeutic index.

Kallus S, Englinger B, Senkiv J, Laemmerer A, Heffeter P, Berger W, Kowol CR, Keppler BK.

Nanomedicine. 2018 Nov;14(8):2632-2643. doi: 10.1016/j.nano.2018.08.001. Epub 2018 Aug 16.

PMID:
30121385
24.

Politics and Professionalism.

Berger W.

Ann Intern Med. 2018 Aug 7;169(3):203-204. doi: 10.7326/L18-0240. No abstract available.

PMID:
30083713
25.

TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma.

Spiegl-Kreinecker S, Lötsch D, Neumayer K, Kastler L, Gojo J, Pirker C, Pichler J, Weis S, Kumar R, Webersinke G, Gruber A, Berger W.

Neuro Oncol. 2018 Nov 12;20(12):1584-1593. doi: 10.1093/neuonc/noy104.

PMID:
30010853
26.

Secondary immune thrombocytopenia (ITP) as an initial presentation of Whipple's disease.

Priest DH, Grote TH, Staley SL, Berger WS, Norman ES, Smith BS.

IDCases. 2017 Jun 28;12:e4-e6. doi: 10.1016/j.idcr.2017.05.010. eCollection 2018.

27.

Early scars are forever: Childhood abuse in patients with adult-onset PTSD is associated with increased prevalence and severity of psychiatric comorbidity.

Gekker M, Coutinho ESF, Berger W, Luz MPD, Araújo AXG, Pagotto LFADC, Marques-Portella C, Figueira I, Mendlowicz MV.

Psychiatry Res. 2018 Sep;267:1-6. doi: 10.1016/j.psychres.2018.05.042. Epub 2018 May 29.

PMID:
29879599
28.

Altered membrane rigidity via enhanced endogenous cholesterol synthesis drives cancer cell resistance to destruxins.

Heilos D, Röhrl C, Pirker C, Englinger B, Baier D, Mohr T, Schwaiger M, Iqbal SM, van Schoonhoven S, Klavins K, Eberhart T, Windberger U, Taibon J, Sturm S, Stuppner H, Koellensperger G, Dornetshuber-Fleiss R, Jäger W, Lemmens-Gruber R, Berger W.

Oncotarget. 2018 May 22;9(39):25661-25680. doi: 10.18632/oncotarget.25432. eCollection 2018 May 22.

29.

Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells.

Molnár E, Rittler D, Baranyi M, Grusch M, Berger W, Döme B, Tóvári J, Aigner C, Tímár J, Garay T, Hegedűs B.

BMC Cancer. 2018 May 8;18(1):542. doi: 10.1186/s12885-018-4455-x.

30.

Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo.

Laszlo V, Valko Z, Kovacs I, Ozsvar J, Hoda MA, Klikovits T, Lakatos D, Czirok A, Garay T, Stiglbauer A, Helbich TH, Gröger M, Tovari J, Klepetko W, Pirker C, Grusch M, Berger W, Hilberg F, Hegedus B, Dome B.

Clin Cancer Res. 2018 Aug 1;24(15):3729-3740. doi: 10.1158/1078-0432.CCR-17-1507. Epub 2018 May 3.

PMID:
29724868
31.

Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis.

Groza D, Gehrig S, Kudela P, Holcmann M, Pirker C, Dinhof C, Schueffl HH, Sramko M, Hoebart J, Alioglu F, Grusch M, Ogris M, Lubitz W, Keppler BK, Pashkunova-Martic I, Kowol CR, Sibilia M, Berger W, Heffeter P.

Oncoimmunology. 2018 Feb 16;7(5):e1424676. doi: 10.1080/2162402X.2018.1424676. eCollection 2018.

32.

Cystoid edema, neovascularization and inflammatory processes in the murine Norrin-deficient retina.

Beck SC, Karlstetter M, Garcia Garrido M, Feng Y, Dannhausen K, Mühlfriedel R, Sothilingam V, Seebauer B, Berger W, Hammes HP, Seeliger MW, Langmann T.

Sci Rep. 2018 Apr 13;8(1):5970. doi: 10.1038/s41598-018-24476-y.

33.

FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal.

Schelch K, Wagner C, Hager S, Pirker C, Siess K, Lang E, Lin R, Kirschner MB, Mohr T, Brcic L, Marian B, Holzmann K, Grasl-Kraupp B, Krupitza G, Laszlo V, Klikovits T, Dome B, Hegedus B, Garay T, Reid G, van Zandwijk N, Klepetko W, Berger W, Grusch M, Hoda MA.

Carcinogenesis. 2018 Apr 5;39(4):534-545. doi: 10.1093/carcin/bgy018.

PMID:
29635378
34.

Human tripartite motif protein 52 is required for cell context-dependent proliferation.

Benke S, Agerer B, Haas L, Stöger M, Lercher A, Gabler L, Kiss I, Scinicariello S, Berger W, Bergthaler A, Obenauf AC, Versteeg GA.

Oncotarget. 2018 Feb 5;9(17):13565-13581. doi: 10.18632/oncotarget.24422. eCollection 2018 Mar 2.

35.

Design, synthesis, nuclear localization, and biological activity of a fluorescent duocarmycin analog, HxTfA.

Kiakos K, Englinger B, Yanow SK, Wernitznig D, Jakupec MA, Berger W, Keppler BK, Hartley JA, Lee M, Patil PC.

Bioorg Med Chem Lett. 2018 May 1;28(8):1342-1347. doi: 10.1016/j.bmcl.2018.03.016. Epub 2018 Mar 5.

PMID:
29548574
36.

Bioimaging of isosteric osmium and ruthenium anticancer agents by LA-ICP-MS.

Klose MHM, Theiner S, Kornauth C, Meier-Menches SM, Heffeter P, Berger W, Koellensperger G, Keppler BK.

Metallomics. 2018 Mar 1;10(3):388-396. doi: 10.1039/c8mt00012c. Epub 2018 Mar 7.

PMID:
29513313
37.

Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial.

Berger W, Sher E, Gawchik S, Fineman S.

Allergy Asthma Proc. 2018 Mar 1;39(2):110-116. doi: 10.2500/aap.2018.39.4116.

38.

Effects of COMT genotype and tolcapone on lapses of sustained attention after sleep deprivation in healthy young men.

Valomon A, Holst SC, Borrello A, Weigend S, Müller T, Berger W, Sommerauer M, Baumann CR, Landolt HP.

Neuropsychopharmacology. 2018 Jun;43(7):1599-1607. doi: 10.1038/s41386-018-0018-8. Epub 2018 Feb 5.

PMID:
29472644
39.

Dynamics of CRISPR/Cas9-mediated genomic editing of the AXL locus in hepatocellular carcinoma cells.

Scharf I, Bierbaumer L, Huber H, Wittmann P, Haider C, Pirker C, Berger W, Mikulits W.

Oncol Lett. 2018 Feb;15(2):2441-2450. doi: 10.3892/ol.2017.7605. Epub 2017 Dec 13.

40.

CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model.

Mayr L, Pirker C, Lötsch D, Van Schoonhoven S, Windhager R, Englinger B, Berger W, Kubista B.

Oncotarget. 2017 Dec 9;8(69):114095-114108. doi: 10.18632/oncotarget.23125. eCollection 2017 Dec 26.

41.

Exome analysis in 34 sudden unexplained death (SUD) victims mainly identified variants in channelopathy-associated genes.

Neubauer J, Lecca MR, Russo G, Bartsch C, Medeiros-Domingo A, Berger W, Haas C.

Int J Legal Med. 2018 Jul;132(4):1057-1065. doi: 10.1007/s00414-018-1775-y. Epub 2018 Jan 19.

PMID:
29350269
42.

A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma.

Meltzer EO, Berger WE.

Allergy Asthma Proc. 2018 Jan 6;39(1):14-26. doi: 10.2500/aap.2018.39.4103. Review.

PMID:
29279056
43.

Metal drugs become targeted.

Fuereder T, Berger W.

ESMO Open. 2017 Aug 17;2(3):e000239. doi: 10.1136/esmoopen-2017-000239. eCollection 2017. No abstract available.

44.

Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.

Brouwer TF, Vehmeijer JT, Kalkman DN, Berger WR, van den Born BH, Peters RJ, Knops RE.

Diabetes Care. 2018 Jun;41(6):1142-1148. doi: 10.2337/dc17-1722. Epub 2017 Dec 6.

PMID:
29212825
45.

Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma.

Klikovits T, Stockhammer P, Laszlo V, Dong Y, Hoda MA, Ghanim B, Opitz I, Frauenfelder T, Nguyen-Kim TDL, Weder W, Berger W, Grusch M, Aigner C, Klepetko W, Dome B, Renyi-Vamos F, Oehler R, Hegedus B.

Sci Rep. 2017 Nov 28;7(1):16456. doi: 10.1038/s41598-017-16551-7.

46.

Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development.

Meier-Menches SM, Gerner C, Berger W, Hartinger CG, Keppler BK.

Chem Soc Rev. 2018 Feb 5;47(3):909-928. doi: 10.1039/c7cs00332c. Review.

PMID:
29170783
47.

FGF5 is expressed in melanoma and enhances malignancy in vitro and in vivo.

Ghassemi S, Vejdovszky K, Sahin E, Ratzinger L, Schelch K, Mohr T, Peter-Vörösmarty B, Brankovic J, Lackner A, Leopoldi A, Meindl D, Pirker C, Hegedus B, Marian B, Holzmann K, Grasl-Kraupp B, Heffeter P, Berger W, Grusch M.

Oncotarget. 2017 Sep 23;8(50):87750-87762. doi: 10.18632/oncotarget.21184. eCollection 2017 Oct 20.

48.

Can we spice up our Christmas dinner? : Busting the myth of the 'Chinese restaurant syndrome'.

van den Berg NWE, Neefs J, Berger WR, Baalman SWE, Meulendijks E, Kawasaki M, Kemper EM, Piersma FR, Veldkamp MW, Wesselink R, Krul SPJ, de Groot JR.

Neth Heart J. 2017 Dec;25(12):664-668. doi: 10.1007/s12471-017-1053-5.

49.

Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma.

Johnson TG, Schelch K, Cheng YY, Williams M, Sarun KH, Kirschner MB, Kao S, Linton A, Klebe S, McCaughan BC, Lin RCY, Pirker C, Berger W, Lasham A, van Zandwijk N, Reid G.

J Thorac Oncol. 2018 Feb;13(2):258-272. doi: 10.1016/j.jtho.2017.10.016. Epub 2017 Nov 4.

50.

A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma.

Meltzer EO, Berger WE.

Allergy Asthma Proc. 2017 Nov 6. doi: 10.2500/aap.2017.38.1403. [Epub ahead of print]

PMID:
29108533

Supplemental Content

Loading ...
Support Center